Tag:
Deals
Latest Headlines
Latest Headlines
Viral vector tech nets Targeted save
Genzyme last week aided in the rescue of Targeted Genetics, a developer of adeno-associated viral (AAV) vector technology. AAV is a naturally occurring virus unassociated with disease in humans.
